New anilinophthalazines as potent and orally well absorbed inhibitors of the VEGF receptor tyrosine kinases useful as antagonists of tumor-driven angiogenesis
Bold
G
Altmann
KH
Frei
J
Lang
M
Manley
PW
Traxler
P
Wietfeld
B
Bruggen
J
Buchdunger
E
Cozens
R
Ferrari
S
Furet
P
Hofmann
F
Martiny-Baron
G
Mestan
J
Rosel
J
Sills
M
Stover
D
Acemoglu
F
Boss
E
Emmenegger
R
Lasser
L
Masso
E
Roth
R
Schlachter
C
Vetterli
W